A key role of microRNA-26a in the scar formation after glaucoma filtration surgery

References

• Wallace DM, Clark AF, Lipson KE, et al. Anti-connective tissue growth factor antibody treatment reduces extracellular matrix production in trabecular meshwork and lamina cribrosa cells. Invest Ophthalmol Vis Sci. 2013;54:7836–7848.
   PubMed Web of Science ®Google Scholar
• Balendra SI, Shah PA, Jain M, et al. Glaucoma: Hot Topics in Pharmacology. Curr Pharm Des. 2017;23:596–607.
   PubMed Web of Science ®Google Scholar
• Riva I, Roberti G, Oddone F, et al. Ahmed glaucoma valve implant: surgical technique and complications. Clin Ophthalmol. 2017;11:357–367.
   PubMed Web of Science ®Google Scholar
• Matlach J, Hipp M, Wagner M, et al. A comparative study of a modified filtering trabeculotomy and conventional trabeculectomy. Clin Ophthalmol. 2015;9:483–492.
   PubMed Web of Science ®Google Scholar
• Manners T, Salmon JF, Barron A, et al. Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucoma. Br J Ophthalmol. 2001;85:159–163.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Sawada A, Mayama C, et al. The 5-year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C: collaborative bleb-related infection incidence and treatment study 2. Ophthalmology. 2014;121:1001–1006.
   PubMed Web of Science ®Google Scholar
• Van de Velde S, Van Bergen T, Vandewalle E, et al. Rho kinase inhibitor AMA0526 improves surgical outcome in a rabbit model of glaucoma filtration surgery. Prog Brain Res. 2015;220:283–297.
   PubMed Web of Science ®Google Scholar
• Chen N, Guo D, Guo Y, et al. Paclitaxel inhibits cell proliferation and collagen lattice contraction via TGF-β signaling pathway in human Tenon's fibroblasts in vitro. Eur J Pharmacol. 2016;777:33–40.
   PubMed Web of Science ®Google Scholar
• Chung EJ, Sohn YH, Kwon SH, et al. Lithium chloride inhibits TGF-beta1-induced myofibroblast transdifferentiation via PI3K/Akt pathway in cultured fibroblasts from Tenon's capsule of the human eye. Biotechnol Lett. 2014;36:1217–1224.
   PubMed Web of Science ®Google Scholar
• Kok HM, Falke LL, Goldschmeding R, et al. Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease. Nat Rev Nephrol. 2014;10:700–711.
   PubMed Web of Science ®Google Scholar
• Klaassen I, van Geest RJ, Kuiper EJ, et al. The role of CTGF in diabetic retinopathy. Exp Eye Res. 2015;133:37–48.
   PubMed Web of Science ®Google Scholar
• Cora D, Re A, Caselle M, et al. MicroRNA-mediated regulatory circuits: outlook and perspectives. Phys Biol. 2017;14:045001.
   PubMed Web of Science ®Google Scholar
• Adams BD, Parsons C, Walker L, et al. Targeting noncoding RNAs in disease. J Clin Invest. 2017;127:761–771.
   PubMed Web of Science ®Google Scholar
• Liu CH, Wang Z, Sun Y, et al. Retinal expression of small non-coding RNAs in a murine model of proliferative retinopathy. Sci Rep. 2016;6:33947.
   PubMed Web of Science ®Google Scholar
• Tkatchenko AV, Luo X, Tkatchenko TV, et al. Large-Scale microRNA expression profiling identifies putative retinal miRNA-mRNA signaling pathways underlying form-deprivation myopia in mice. PLoS ONE. 2016;11:e0162541.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Takanashi M, Sudo K, et al. Novel form of miR-29b suppresses bleomycin-induced pulmonary fibrosis. PloS ONE. 2017;12:e0171957.
   PubMed Web of Science ®Google Scholar
• Li X, Liu L, Shen Y, et al. MicroRNA-26a modulates transforming growth factor beta-1-induced proliferation in human fetal lung fibroblasts. Biochem Biophys Res Commun. 2014;454:512–517.
   PubMed Web of Science ®Google Scholar
• Su Y, Jiang C, Zhang L, et al. Arsenic trioxide inhibits proliferation of rabbit Tenon's capsule fibroblasts after trabeculectomy by downregulating expression of extracellular matrix proteins. Invest Ophthalmol Vis Sci. 2015;56:6663–6670.
   PubMed Web of Science ®Google Scholar
• Ooi JY, Bernardo BC, McMullen JR. Therapeutic potential of targeting microRNAs to regulate cardiac fibrosis: miR-433 a new fibrotic player. Ann Transl Med. 2016;4:548.
   PubMed Web of Science ®Google Scholar
• Oglesby IK, McKiernan PJ. MiRNA expression in cystic fibrosis bronchial epithelial cells. Methods Mol Biol. 2017;1509:57–69.
   PubMedGoogle Scholar
• Liang H, Xu C, Pan Z, et al. The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis. Mol Therap. 2014;22:1122–1133.
   PubMed Web of Science ®Google Scholar
• Dey N, Bera A, Das F, et al. High glucose enhances microRNA-26a to activate mTORC1 for mesangial cell hypertrophy and matrix protein expression. Cell Signal. 2015;27:1276–1285.
   PubMed Web of Science ®Google Scholar
• Lin G, Liu B, Meng Z, et al. MiR-26a enhances invasive capacity by suppressing GSK3β in human lung cancer cells. Exp Cell Res. 2017;352:364–374.
   PubMed Web of Science ®Google Scholar
• Chen J, Xu Y, Tao L, et al. MiRNA-26a contributes to the acquisition of malignant behaviors of doctaxel-resistant lung adenocarcinoma cells through targeting EZH2. Cell Physiol Biochem. 2017;41:583–597.
   PubMed Web of Science ®Google Scholar
• Koga K, Yokoi H, Mori K, et al. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy. Diabetologia. 2015;58:2169–2180.
   PubMed Web of Science ®Google Scholar
• Ubink I, Verhaar ER, Kranenburg O, et al. A potential role for CCN2/CTGF in aggressive colorectal cancer. J Cell Commun Signal. 2016;10:223–227.
   PubMed Web of Science ®Google Scholar
• Wang S, Li B, Li C, et al. Potential renoprotective agents through inhibiting CTGF/CCN2 in diabetic nephropathy. J Diabetes Res. 2015;2015:962383.
   PubMed Web of Science ®Google Scholar
• Rosenbloom J, Ren S, Macarak E. New frontiers in fibrotic disease therapies: the focus of the Joan and Joel Rosenbloom Center for Fibrotic Diseases at Thomas Jefferson University. Matrix Biol. 2016;51:14–25.
   PubMed Web of Science ®Google Scholar